MYEOV is a prognostic factor in multiple myeloma
Jerome Moreaux1, Dirk Hose, Amélie Bonnefond
1CHU Montpellier, Institute of Research in Biotherapy, Hopital St Eloi, Av. Augustin Fliche, Montpellier Cedex 5, France.
Experimental Hematology
|September 22, 2010
Summary
The MYEOV gene is overexpressed in multiple myeloma cells and its presence predicts a poorer prognosis. Downregulating MYEOV inhibits cancer cell growth, suggesting it as a therapeutic target for multiple myeloma.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Multiple myeloma is a fatal plasma cell cancer.
- Current treatments offer limited cures.
- Gene expression analysis may reveal new therapeutic targets.
Purpose of the Study:
- To investigate the role of the MYEOV gene in multiple myeloma.
- To determine if MYEOV expression is a prognostic marker.
Main Methods:
- Gene expression profiling using Affymetrix microarrays.
- Analysis of MYEOV gene expression in 171 newly diagnosed multiple myeloma patients.
- MYEOV gene downregulation and knockout experiments in myeloma cell lines.
Main Results:
- MYEOV was overexpressed in 79% of multiple myeloma cells versus 15% of normal plasma cells.
- MYEOV downregulation reduced myeloma cell growth.
- MYEOV expression predicted shorter event-free survival and a trend for reduced overall survival.
- MYEOV is an independent prognostic factor for multiple myeloma.
Conclusions:
- MYEOV gene expression is a significant prognostic factor in multiple myeloma.
- MYEOV plays a role in controlling multiple myeloma cell proliferation.
- Targeting MYEOV may offer a new therapeutic strategy.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...